Company Filing History:
6 out of 8,758 
3 out of 978 
1 out of 832,961 Years Active: 1997-2011
Certainly! Here is the article about inventor Michael S Noone:
Title: Innovator Spotlight: Michael S Noone from Londonderry, NH
Introduction:
Michael S Noone is a prolific inventor hailing from Londonderry, NH, with an impressive portfolio of 10 patents to his name. His groundbreaking work in the medical field has revolutionized treatments for vascular conditions, showcasing his ingenuity and dedication to innovation.
Latest Patents:
1. Guiding catheter with resiliently compressible occluder: Noone's invention of a guiding catheter with a resiliently compressible occluder is designed to provide proximal occlusion while intubating a branch vessel lumen in a patient. This catheter's unique design offers enhanced precision and safety in medical procedures.
2. Embolic containment system with asymmetric frictional control: His second latest patent features an embolic containment system that incorporates asymmetric frictional control to treat vascular conditions effectively. This system, along with a guidewire-based embolic filter, highlights Noone's commitment to advancing medical technologies.
Career Highlights:
Having worked at renowned companies like Medtronic, Inc. and Medtronic Vascular, Inc., Noone's career is distinguished by his contributions to the medical device industry. His innovative solutions have had a profound impact on patient care and treatment outcomes, solidifying his reputation as a trailblazer in the field.
Collaborations:
Throughout his career, Noone has collaborated with industry experts such as Albert Harold Dunfee and Mark A Johanson. These partnerships have led to the development of cutting-edge medical devices and technologies that have set new standards in the healthcare sector.
Conclusion:
In conclusion, Michael S Noone's inventive spirit and unwavering dedication to improving healthcare have cemented his legacy as a pioneering inventor in the field of medical technology. His patents continue to shape the landscape of vascular treatments, offering hope and better outcomes for patients worldwide.